Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer

NCT00146276 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

178

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Carcinoma, Transitional Cell

Interventions

DRUG: gemcitabine

Sponsor

Association of Urologic Oncology (AUO)

Collaborators

[object Object]